SGLT2 Inhibitors and Risk Reduction for Mortality in High-Risk Patients: A Meta-Analysis of Randomized Controlled Trials.

Siddiqi TJ, Butler J, Coats AJS, Verma S, Friede T, Filippatos G, Anker SD (2023). Global Cardiology.

Folgen Sie uns